Anderson Cynthia Lynn - Insider Non-Derivative Transactions at VistaGen Therapeutics, Inc. (VTGN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 28, 2024, Anderson Cynthia Lynn's relationship to VistaGen Therapeutics, Inc. (VTGN) is Officer (CHIEF FINANCIAL OFFICER), and currently has 3,592 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VTGN insiders.
Data Source: SEC.
Anderson Cynthia Lynn - Insider Non-Derivative Transactions at VTGN
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jun 29, 2024 | Acquisition -- (Common Stock) | 3592 | 2.96 | 3592 |